BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/10/2022 10:51:02 AM | Browse: 509 | Download: 1399
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 67296
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title EFNA1 in gastrointestinal cancer: Expression, regulation and clinical significance
Manuscript Source Invited Manuscript
All Author List Ling-Yu Chu, Bin-Liang Huang, Xu-Chun Huang, Yu-Hui Peng, Jian-Jun Xie and Yi-Wei Xu
Funding Agency and Grant Number
Funding Agency Grant Number
Natural Science Foundation of China 81972801
Guangdong Basic and Applied Basic Research Foundation 2019A1515011873
Medical Project of Science and Technology Planning of Shantou 200605115266724
2020 Li Ka Shing Foundation Cross-Disciplinary Research Grant 2020LKSFG01B
Corresponding Author Yi-Wei Xu, PhD, Research Associate, Department of Clinical Laboratory Medicine, The Cancer Hospital of Shantou University Medical College, No. 7 Raoping road, Shantou 515041, Guangdong Province, China. 14yyxu@stu.edu.cn
Key Words EFNA1; Expression; Tumorigenesis; Clinical implication; gastrointestinal cancer
Core Tip Ephrin-A1, a protein that in humans is encoded by the EFNA1 gene, is the ligand of EphA2. Studies have shown that the EphA2 receptor and its ligand ephrin-A1 are expressed in a variety of malignant tumors and the interaction between the two promotes the migration of tumor vascular endothelial cells. In addition, studies have shown that EFNA1 widely affects tumor growth through enhancing tumor angiogenesis, malignant cell events and invasiveness. EFNA1 is also up-regulated in gastrointestinal tumors and is closely related to the prognosis of gastrointestinal tumors. Therefore, this article reviews the expression, prognostic value, regulation and clinical significance of EFNA1 in gastrointestinal tumors.
Publish Date 2022-05-10 09:43
Citation Chu LY, Huang BL, Huang XC, Peng YH, Xie JJ, Xu YW. EFNA1 in gastrointestinal cancer: Expression, regulation and clinical significance. World J Gastrointest Oncol 2022; 14(5): 973-988
URL https://www.wjgnet.com/1948-5204/full/v14/i5/973.htm
DOI https://dx.doi.org/10.4251/wjgo.v14.i5.973
Full Article (PDF) WJGO-14-973.pdf
Full Article (Word) WJGO-14-973.docx